CAC40: back in the green, weekly loss of -1.3%

(CercleFinance.com) - Up by just 0.
1% at around 7510, the CAC40 began the session close to equilibrium on Friday, as investors' attention could be focused on the numerous corporate publications released since last night.

Sanofi has just reported a 17.6% increase in business EPS at constant exchange rates for the third quarter of 2024, with sales growth of almost 16% 'reflecting the dynamic of the product portfolio'.

"This performance was underpinned by a favorable sequence of sales of influenza vaccines and Beyfortus, 67% growth in our new medicines, as well as volume-driven growth in Dupixent", explains CEO Paul Hudson.

Claiming a good performance to end September, Safran raises its ROC target for 2024, despite a lowered sales target in the wake of its original equipment deliveries forecasts for short- and medium-haul aircraft.

Among the day's other quarterly publications in Paris, traders will also be able to react to those of Vinci, Accor, Valéo and Unibail-Rodamco-Westfield last night, as well as Groupe Seb, Bolloré, Nexity, Wendel and Rémy Cointreau.

In terms of the day's data, traders will be paying particular attention to Germany's Ifo business climate index in the morning, followed by France's jobless figures for the third quarter at midday.

German business sentiment is up slightly, according to the ifo business climate index, which rose from 85.4 in September to 86.5 this month, whereas Capital Economics was expecting it to fall slightly to 85.

In France, household confidence fell slightly for the first time since April, according to Insee's synthetic indicator, which fell by one point to 94 in October, and thus remains below its long-term average (100).

On the other side of the Atlantic, the afternoon will see the release of US durable goods orders for last month, followed by the University of Michigan's consumer confidence index in final figures for October.

Copyright (c) 2024 CercleFinance.com. All rights reserved.